C
CORIOLIS PHARMA RESEARCH GMBH
Coriolis Pharma is your expert contract research organization (CRO) for formulation development and analytical services for biopharmaceuticals & vaccines.
Country/Area ：Germany
Company Email ：info@coriolis-pharma.com
Industry ：Manufacturing GeneralManufacturing
Company address ：Planegg
Company website ：*****
Company phone ：+49 894177600
Established ：2008
Company Revenue ：$18,568,000
Number of employees ：106
SIC Code ：28283
NAICS Code ：32325
Company News
KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma
Oct 16, 2023
MUNICH--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced, in partnership with Flerie, the formation of a new global pharma services platform, Frontier Biosolutions (“Frontier”), which will invest in a portfolio of companies focused on specialized pharmaceutical services to advanced therapeutics customers. Frontier will invest in differentiated scientific capabilities and proprietary technology platforms that address critical bottlenecks in the development and manufacturin
Oct 16, 2023
Coriolis Pharma Appoints Silvia Steyrer-Gruber as New Chief Executive Officer - B3C newswireMay 4, 2022
Coriolis Pharma announced that Silvia Steyrer-Gruber has been named as Chief Executive Officer.
May 4, 2022Web Summary
Q1: What is the address of Coriolis Pharma Research GmbH?
A1: Unfortunately, the provided text does not explicitly mention the company's physical address. However, it can be inferred that as a research-focused company, they might have multiple locations or facilities for their operations.
Q2: What products or therapeutic areas does Coriolis Pharma Research GmbH specialize in?
A2: According to the provided content, Coriolis Pharma Research GmbH specializes in various biopharmaceutical drug products, including antibody or antibody-related peptide therapeutic proteins, gene and cell therapy, viral vectors, nucleic acid vaccines, nanoparticulate delivery systems, and more. They also have expertise in highly concentrated protein formulations.
Q3: What industry does Coriolis Pharma Research GmbH operate within?
A3: Based on the information provided, it can be inferred that Coriolis Pharma Research GmbH operates within the biopharmaceutical industry, specifically focusing on stability studies for drug products and development services for various therapeutic areas.
Q4: What services does Coriolis Pharma Research GmbH offer in terms of stability studies?
A4: Coriolis Pharma Research GmbH offers comprehensive stability study services, including preformulation studies, formulation development, lyophilization process development, comparability studies, in-use stability studies, forced degradation studies, biopharmaceutical process development, and developability assessment. They also provide analytical services such as aggregate analytics, particle characterization, and higher-order structure analysis.
Q5: What types of climate chambers does Coriolis Pharma Research GmbH use for stability studies?
A5: According to the provided content, Coriolis Pharma Research GmbH uses suitable climate chambers at controlled temperatures and relative humidity (RH) conditions, including standard storage conditions such as frozen storage, -80°C, 25°C at 60% RH, and other temperature and relative humidity conditions.
Q6: What is the scope of Coriolis Pharma Research GmbH's expertise in stability studies?
A6: The company has worked with over 930 modalities and has extensive experience designing stability studies for all phases of drug development, including preclinical, early-phase, late-phase, and commercialization. They have expertise in various biopharmaceutical drug products, including highly concentrated protein formulations and live virus vaccines.
Q7: What is the purpose of Coriolis Pharma Research GmbH's stability study services?
A7: The primary purpose of Coriolis Pharma Research GmbH's stability study services is to ensure the efficacy, quality, and safety of drug products over their intended shelf life. Their services also support formulation development, quality assurance, and regulatory filings (IND, IMPD, BLA), offering efficiency and lowering risks in later development phases.
Q8: What resources or publications does Coriolis Pharma Research GmbH provide for stability study information?
A8: The company provides various resources and publications on their website, including articles, publications, and webinars. These resources offer insights into their expertise, services, and research findings related to stability studies and biopharmaceutical development.
A1: Unfortunately, the provided text does not explicitly mention the company's physical address. However, it can be inferred that as a research-focused company, they might have multiple locations or facilities for their operations.
Q2: What products or therapeutic areas does Coriolis Pharma Research GmbH specialize in?
A2: According to the provided content, Coriolis Pharma Research GmbH specializes in various biopharmaceutical drug products, including antibody or antibody-related peptide therapeutic proteins, gene and cell therapy, viral vectors, nucleic acid vaccines, nanoparticulate delivery systems, and more. They also have expertise in highly concentrated protein formulations.
Q3: What industry does Coriolis Pharma Research GmbH operate within?
A3: Based on the information provided, it can be inferred that Coriolis Pharma Research GmbH operates within the biopharmaceutical industry, specifically focusing on stability studies for drug products and development services for various therapeutic areas.
Q4: What services does Coriolis Pharma Research GmbH offer in terms of stability studies?
A4: Coriolis Pharma Research GmbH offers comprehensive stability study services, including preformulation studies, formulation development, lyophilization process development, comparability studies, in-use stability studies, forced degradation studies, biopharmaceutical process development, and developability assessment. They also provide analytical services such as aggregate analytics, particle characterization, and higher-order structure analysis.
Q5: What types of climate chambers does Coriolis Pharma Research GmbH use for stability studies?
A5: According to the provided content, Coriolis Pharma Research GmbH uses suitable climate chambers at controlled temperatures and relative humidity (RH) conditions, including standard storage conditions such as frozen storage, -80°C, 25°C at 60% RH, and other temperature and relative humidity conditions.
Q6: What is the scope of Coriolis Pharma Research GmbH's expertise in stability studies?
A6: The company has worked with over 930 modalities and has extensive experience designing stability studies for all phases of drug development, including preclinical, early-phase, late-phase, and commercialization. They have expertise in various biopharmaceutical drug products, including highly concentrated protein formulations and live virus vaccines.
Q7: What is the purpose of Coriolis Pharma Research GmbH's stability study services?
A7: The primary purpose of Coriolis Pharma Research GmbH's stability study services is to ensure the efficacy, quality, and safety of drug products over their intended shelf life. Their services also support formulation development, quality assurance, and regulatory filings (IND, IMPD, BLA), offering efficiency and lowering risks in later development phases.
Q8: What resources or publications does Coriolis Pharma Research GmbH provide for stability study information?
A8: The company provides various resources and publications on their website, including articles, publications, and webinars. These resources offer insights into their expertise, services, and research findings related to stability studies and biopharmaceutical development.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
